Atlas Trials

Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens

Clinical trial NCT01948141 · COMPLETED

Trial details

NCT number
NCT01948141
Sponsor
Roswell Park Cancer Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Non-small Cell Lung CancerSquamous Cell Lung CancerStage III Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Start date
2014-01-30
Primary completion
2016-08-16
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.